Prime Capital Investment Advisors, LLC Krystal Biotech, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.88 Billion
- Q3 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 2,591 shares of KRYS stock, worth $437,982. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,591
Previous 1,342
93.07%
Holding current value
$437,982
Previous $246,000
91.46%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KRYS
# of Institutions
311Shares Held
24.4MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$667 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$482 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$443 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$246 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$167 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.34B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...